Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Army
Federal Trade Commission
McKesson
Covington
UBS
Deloitte
Cerilliant
US Department of Justice

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040253

« Back to Dashboard

NDA 040253 describes ETHOSUXIMIDE, which is a drug marketed by Akorn, Bionpharma Inc, Heritage Pharms Inc, Mikart, Pharm Assoc, and Teva Pharms, and is included in six NDAs. It is available from nine suppliers. Additional details are available on the ETHOSUXIMIDE profile page.

The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
Summary for 040253
Tradename:ETHOSUXIMIDE
Applicant:Pharm Assoc
Ingredient:ethosuximide
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Pharmacology for NDA: 040253
Medical Subject Heading (MeSH) Categories for 040253
Suppliers and Packaging for NDA: 040253
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ETHOSUXIMIDE ethosuximide SYRUP;ORAL 040253 ANDA Pharmaceutical Associates, Inc. 0121-0670 N 0121-0670-16

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength250MG/5ML
Approval Date:Nov 22, 2000TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Accenture
Merck
McKinsey
Johnson and Johnson
Cipla
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.